MedTrace Logo

GI Alpha-Gal Study

NCT06268717 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-10-20

No results posted yet for this study

Summary

This is a double-blind, crossover food challenge study using pork with and without α-gal in patients with a clinical diagnosis of gastrointestinal (GI)- α-gal allergy, and to investigate the pathophysiology underlying their symptoms.

Conditions

Interventions

OTHER

Ground pork containing alpha-gal

150 grams of cooked, ground pork meat containing alpha-gal sugar eaten once

OTHER

Pork meat not containing alpha-gal

150 grams of cooked, ground pork meat not containing alpha-gal sugar

Sponsors & Collaborators

  • Revivicor, Inc

    collaborator UNKNOWN

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Sarah McGill, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2026-06-02
Completion
2026-06-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06268717 on ClinicalTrials.gov